title: Curcumin adds spice to the debate: lipid metabolism in liver disease.
abstract: Activated hepatic stellate cells (HSCs), the major source of the collagens involved in fibrosis and non-alcoholic fatty liver disease (NAFLD), undergo a profound loss of lipid and vitamin A storage capacity, as a consequence of a decline in expression of 'adipogenic' transcription factors such as peroxisome proliferator-activated receptor-gamma (PPARgamma). By contrast, hepatocytes undergo a micro- and macro-vesicular steatosis, reflecting the accumulation of triacylglycerol, and associated with chronic inflammation and fibrosis. These paradoxical findings are extended in this issue: Kang and Chen demonstrate that while low-density lipoproteins (LDL) can activate HSCs, curcumin can inhibit this process by activation of PPARgamma, which not only represses gene expression of SREBP-2 and LDLR, but via induction of expression of SREBP-1c, restores the lipid storage capacity characteristic of quiescent HSCs, suggesting that curcumin may be of therapeutic usage in protecting against liver steatosis and fibrosis.
authors.affiliation: Vascular Biology Group, Department of Biological and Biomedical Sciences, Glasgow Caledonian University, Glasgow, UK. Ann.Graham@gcal.ac.uk
authors.forename: Annette
authors.initials: A
authors.lastname: Graham
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D003474:Curcumin / Q000494:pharmacology* / Q000627:therapeutic use; D055166:Hepatic Stellate Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D050356:Lipid Metabolism / Q000187:drug effects*; D008077:Lipoproteins, LDL / Q000378:metabolism; D008107:Liver Diseases / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D047495:PPAR gamma / Q000378:metabolism; D051779:Sterol Regulatory Element Binding Proteins / Q000378:metabolism
chemical_list: D008077:Lipoproteins, LDL; D047495:PPAR gamma; D051779:Sterol Regulatory Element Binding Proteins; D003474:Curcumin
references.citation: Keio J Med. 2005 Dec;54(4):190-2
references.pmid: 16452829
references.citation: J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S102-5
references.pmid: 16958658
references.citation: Physiol Rev. 2008 Jan;88(1):125-72
references.pmid: 18195085
references.citation: J Nutr Biochem. 2007 Feb;18(2):113-9
references.pmid: 16713233
references.citation: Planta Med. 2008 Sep;74(11):1374-9
references.pmid: 18704882
references.citation: Mol Pharmacol. 2008 Feb;73(2):399-409
references.pmid: 18006644
references.citation: J Biol Chem. 2000 Nov 17;275(46):35715-22
references.pmid: 10969082
references.citation: Br J Pharmacol. 2009 Aug;157(8):1354-67
references.pmid: 19594758
references.citation: Biochem Pharmacol. 2008 Feb 15;75(4):787-809
references.pmid: 17900536
references.citation: J Biol Chem. 2004 Mar 19;279(12):11392-401
references.pmid: 14702344
references.citation: Br J Pharmacol. 2008 Feb;153(3):557-67
references.pmid: 17965732